Iclusig 10 & 15 MG
Ended Awarded
- Contract number
- 36C24524N0894
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,957
Award facts
- Contract value 100% obligated
- $13,956.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract, valued at $13,956.72, is for the delivery of ICLUSIG 10 & 15 MG, a specialty oncology medication, to various VA medical facilities across the country.
The contract was awarded against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs, and does not have a set-aside designation. This suggests Takeda, as a large, foreign-owned business, is well-positioned to fulfill the VA's requirements for this critical oncology drug. The contract has an ultimate completion date of September 10, 2024, indicating a multi-year agreement to supply ICLUSIG to the VA's Integrated Service Networks (VISNs) nationwide.
This award is likely part of a larger Blanket Purchase Agreement (BPA) that Takeda holds with the VA National Acquisition Center, valued at over $13 million, for the supply of ICLUSIG products. The long-term nature of this BPA underscores Takeda's established relationship with the VA as a key supplier of specialty pharmaceuticals to support the healthcare needs of veterans.
Quick answers
Who was awarded contract 36C24524N0894?
36C24524N0894 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 6, 2024.
How much is contract 36C24524N0894 worth?
The government has obligated $13,957 on 36C24524N0894.
Is contract 36C24524N0894 an order under another contract?
Yes. 36C24524N0894 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0894 competed?
The extent of competition for 36C24524N0894 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award